| Breakdown | Mar 2024 | Mar 2023 | Mar 2023 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.62B | 1.44B | 5.17B | 9.44B | 9.09B |
| Gross Profit | -60.47M | 130.79M | 760.81M | 916.73M | 535.24M |
| EBITDA | -2.15B | -323.19M | 414.63M | -9.84M | -203.82M |
| Net Income | -2.34B | -785.63M | 966.69M | 1.21B | -1.85B |
Balance Sheet | |||||
| Total Assets | 10.21B | 11.52B | 12.65B | 18.27B | 38.19B |
| Cash, Cash Equivalents and Short-Term Investments | 601.40M | 890.20M | 696.11M | 1.38B | 1.40B |
| Total Debt | 1.79B | 1.77B | 1.92B | 4.52B | 12.18B |
| Total Liabilities | 9.82B | 9.02B | 10.11B | 15.88B | 38.90B |
| Stockholders Equity | -1.26B | 1.03B | 1.46B | -462.08M | -1.84B |
Cash Flow | |||||
| Free Cash Flow | -48.21M | -138.10M | -115.49M | -535.80M | 581.72M |
| Operating Cash Flow | -31.02M | -126.82M | -107.99M | -528.72M | 588.26M |
| Investing Cash Flow | -176.83M | -124.68M | -158.34M | -20.22M | -5.32M |
| Financing Cash Flow | -79.82M | 442.45M | 316.98M | -58.62M | -737.61M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
50 Neutral | HK$591.28M | 0.05 | 260.87% | ― | 82.96% | ― | |
42 Neutral | HK$258.04M | -0.10 | -34.31% | ― | -63.41% | 77.97% | |
41 Neutral | HK$473.35M | -0.03 | ― | ― | -64.27% | -19.76% | |
40 Underperform | HK$87.25M | -0.41 | ― | ― | -37.97% | 87.04% | |
39 Underperform | HK$402.21M | 0.33 | -21.15% | ― | 69.55% | 64.09% | |
39 Underperform | HK$212.11M | -0.04 | ― | ― | -60.50% | -103.48% |
Peking University Resources (Holdings) Company Limited has announced a leadership change in its corporate governance team, with company secretary Ms. Leung Mei King resigning and Ms. Zhang Jiabo appointed to the role effective 30 January 2026. Ms. Leung has indicated there are no matters related to her departure that need to be brought to the attention of the stock exchange or shareholders, suggesting a smooth and non-contentious transition. Ms. Zhang, who has overseen finance and administration in the Hong Kong office since 2021 and brings over a decade of experience in finance, auditing, investment and consulting, is expected to strengthen the company’s compliance and governance capabilities, an important area for Hong Kong-listed firms amid ongoing regulatory scrutiny.
The most recent analyst rating on (HK:0618) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on Peking University Resources Holdings Co. Ltd. stock, see the HK:0618 Stock Forecast page.
Peking University Resources (Holdings) Company Limited, through its Dubai-based healthcare arm ResoHealth, is expanding its presence in digital health and medical technology, targeting less digitally advanced healthcare markets with interoperable, cloud-based solutions. The group has partnered with Trivitron Healthcare to launch Trivitron Digital AI, a digital health platform aimed at modernising Tier-2 and Tier-3 hospitals in India by providing integrated, cloud-based tools such as a Lab Information System, Web-PACS and a mobile-first personal health record that meet global interoperability and data standards. Designed to improve operational efficiency, data management and patient engagement while requiring minimal additional infrastructure, the initiative seeks to bridge the digital divide in healthcare and is planned to be rolled out beyond India to Africa, the Middle East and Southeast Asia, positioning the company as a player in the democratisation of digital healthcare access across emerging markets.
The most recent analyst rating on (HK:0618) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on Peking University Resources Holdings Co. Ltd. stock, see the HK:0618 Stock Forecast page.
Peking University Resources (Holdings) Company Limited has changed its Bermuda principal share registrar and transfer agent to Ocorian Services (Bermuda) Limited with effect from 1 January 2025, reflecting an administrative shift in how the company manages its overseas share registration and transfer services. Following this change, the company has issued a clarification that the registrar information disclosed in its annual report for the year ended 31 March 2025 and interim report for the six months ended 30 September 2025 should be updated to reflect Ocorian as the principal registrar, while confirming that all other information in those reports remains unchanged, signalling no impact on its reported financials or operations but ensuring accuracy for shareholders and market participants relying on its corporate records.
The most recent analyst rating on (HK:0618) stock is a Hold with a HK$0.18 price target. To see the full list of analyst forecasts on Peking University Resources Holdings Co. Ltd. stock, see the HK:0618 Stock Forecast page.